Accuron Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accuron Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accuron Technology Today - Breaking & Trending Today

Week In Review: METiS Acquires Pan-RAF Inhibitor In $482 Million Deal

Published: September 18, 2022

Celregen Therapeutics signed a $100 million agreement to in-license China rights for a novel therapy that uses induced Pluripotent Stem Cells to repair bullous keratopathy.

Source: seekingalpha.com

Related Topics:

Hong KongUnited StatesLepu BiopharmaFosun CelregenFosun PharmaWorg PharmaGreater Bay Area FundLepu Medical TechnologySingapore Advanced Medtech HoldingsAccuron TechnologySwiss ExchangeFosun Health Capital New Drug FundUs Treasury Committee On Foreign InvestmentShanghai Roche AcceleratorGlobal Depositary ReceiptsCelregen TherapeuticsPluripotent Stem CellsShanghai Fosun PharmaFosun Health CapitalNew DrugFoster City HangzhouMaxpro Capital AcquisitionBay BioTiger JadeBay Area Fund